Monte Rosa Therapeutics announced a global license agreement with Novartis and a strategic collaboration with Roche.

The entities involved

• Monte Rosa Therapeutics →

  biotechnology company

  Nothing else this week.

• Hoffmann-La Roche →

  Swiss healthcare company

  • Natera's Signatera test is undergoing a Phase III trial across US sites, sponsored by NRG Oncology, while facing patent litigation.Sun 02:44
  • Hoffmann-La Roche opened a new R&D center in Boston.Sat 11:08
• Novartis →

  Swiss-American multinational pharmaceutical corporation

  • Novartis acquired Avidity in a $12 billion purchase, while Trump simultaneously threatened Swiss businesses with tariffs.Sat 01:46
  • GSK and Novartis are identified as major pharmaceutical companies.Fri 02:16

Related events

• Novartis sought Swissmedic regulatory approval for a drug, which was co-funded by Sida and introduced first in Ghana.Sep 15
• Novartis and Hoffmann-La Roche sent campaign contributions to Democrats.Aug 27
• The FDA approved various advanced therapies, including oral medication from Roche, a gene-targeting drug from Biogen, and a one-time gene therapy from Novartis.Sep 14
• Partnership expands Novartis's oncology pipeline.Jun 24
• Novartis is headquartered in Basel, Switzerland.Jun 22